Paper · 47900
Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by H-2K and H-2D serological regions of the murine major histocompatibility complex.
Shearer GM and 2 others. J Exp Med, 1975. Cited by 471 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by H-2K and H-2D serological regions of the murine major histocompatibility complex. Papers, record 47900. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/47900
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by H-2K and H-2D serological regions of the murine major histocompatibility complex.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Histocompatibility Antigens | Major topic |
| Immunity, Cellular | Major topic |
| Lymphocytes | Major topic |
| Animals | |
| Cell Membrane | |
| Cells, Cultured | |
| Chromium Radioisotopes | |
| Cytotoxicity Tests, Immunologic | |
| Epitopes | |
| Genetics | |
| Haptens | |
| Isoantigens | |
| Male | |
| Mice | |
| Mice, Inbred Strains | |
| Spleen | |
| T-Lymphocytes | |
| Trinitrobenzenesulfonic Acid |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,547,153 | Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes. | Eur J Immunol | 1974 | https://conductscience.org/library/papers/4547153 | PubMed |
| 2 | 4,547,543 | Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis. | Nature | 1974 | https://conductscience.org/library/papers/4547543 | PubMed |
| 3 | 47,219 | The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization. | Adv Immunol | 1975 | https://conductscience.org/library/papers/47219 | PubMed |
| 4 | 4,781,392 | Ir-LDHB: map position and functional analysis. | Eur J Immunol | 1973 | https://conductscience.org/library/papers/4781392 | PubMed |
| 5 | 4,825,243 | Genetic control of the immune response to staphylococcal nuclease. I. Ir-Nase: control of the antibody response to nuclease by the Ir region of the mouse H-2 complex. | J Exp Med | 1974 | https://conductscience.org/library/papers/4825243 | PubMed |
| 6 | 4,881,822 | The H-2 locus of the mouse: observations and speculations concerning its comparative genetics and its polymorphism. | Folia Biol (Praha) | 1968 | https://conductscience.org/library/papers/4881822 | PubMed |
| 7 | 4,908,392 | Genetic control of specific immune responses. | Adv Immunol | 1969 | https://conductscience.org/library/papers/4908392 | PubMed |
| 8 | 5,277,103 | Enhanced immunogenicity of chemically-coated syngeneic tumor cells. | Proc Natl Acad Sci U S A | 1971 | https://conductscience.org/library/papers/5277103 | PubMed |
| 9 | 5,513,502 | Quantitative in vitro assay of cytotoxic cellular immunity. | J Natl Cancer Inst | 1970 | https://conductscience.org/library/papers/5513502 | PubMed |
| 10 | 5,675,436 | Phenotypic expressions of the major histocompatibility locus in man (HL-A): leukocyte antigens and mixed leukocyte culture reactivity. | J Exp Med | 1968 | https://conductscience.org/library/papers/5675436 | PubMed |
1 to 10 of 30
See all 30 referencesCited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 471 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 21,302,087 | Detection of two allotype-(Ig-1)-linked minor histocompatibility loci by the use ofH-2-restricted cytotoxic lymphocytes in congenic mice. | Immunogenetics | 1978 | https://conductscience.org/library/papers/21302087 | PubMed |
| 10,516,727 | Protective immunization against melanoma by gp100 DNA-HVJ-liposome vaccine. | Gene Ther | 1999 | https://conductscience.org/library/papers/10516727 | PubMed |
| 7,461,728 | H-2 expression by lymphoid cells of different mouse strains: quantitative interaction of H-2 with monoclonal antibodies and their Fab fragments. | Immunology | 1981 | https://conductscience.org/library/papers/7461728 | PubMed |
| 7,419,247 | Immune response to acute virus infection in the Syrian hamster. I. Studies on genetic restriction of cell-mediated cytotoxicity. | Immunogenetics | 1980 | https://conductscience.org/library/papers/7419247 | PubMed |
| 6,979,047 | Tolerance of thymic cytotoxic T lymphocytes to allogeneic H-2 determinants encountered prethymically: evidence for expression of anti-H-2 receptors prior to entry into the thymus. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6979047 | PubMed |
| 6,976,318 | H-2-Restricted lethal graft-versus-host diseases. | Immunogenetics | 1981 | https://conductscience.org/library/papers/6976318 | PubMed |
| 6,970,297 | [Follow-up study on antibody dependent cell-mediated cytotoxicity and cell-mediated cytotoxicity to HBs-antigen conjugated target cells in patients with hepatitis B (author's transl)]. | Klin Wochenschr | 1980 | https://conductscience.org/library/papers/6970297 | PubMed |
| 6,967,857 | Functional studies of the products of H-2L locus. | Immunogenetics | 1980 | https://conductscience.org/library/papers/6967857 | PubMed |
| 6,955,277 | I-A subregion control of the transfer of delayed type hypersensitivity (DTH). | Immunogenetics | 1982 | https://conductscience.org/library/papers/6955277 | PubMed |
| 6,797,935 | Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes. | Immunology | 1981 | https://conductscience.org/library/papers/6797935 | PubMed |
1 to 10 of 51
See all 51 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/47900
GET https://conductscience.org/api/papers/v1/47900/references?page=2